Antidepressants during pregnancy: risk-benefit study for mother and child

Completed

• Conditions: Depression and pregnancy; Mental and Behavioural Disorders; Depressive episode

• Registration Number: ISRCTN25383361
• Lead Sponsor: niversity Medical Centre Utrecht (UMCU) (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-20
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Women who are pregnant and use one of the modern antidepressants (selective serotonin re-uptake inhibitor [SSRI] and non-SSRI) are included at 16 weeks of pregnancy, group A. Women who stopped taking antidepressants in the first trimester or just before pregnancy are included in group B. Women must be willing and give informed consent and must be able to read in Dutch in order to fill in the questionnaires.

Exclusion Criteria

1. Co-medication with a similar or higher pregnancy risk factor
2. Alcohol or drug addiction

Study & Design

• Study Type: Interventional
• Study Design: Not specified